Harvard Bioscience (HBIO) Cash from Operations Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.57 Bn | 121.35 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 45.01 Bn | 44.20 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 33.11 Bn | 31.45 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.83 Bn | 30.60 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.09 Bn | 22.65 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.11 Bn | 11.05 Bn | 736.59 Mn | -8.92% |
| 10 | Harvard Bioscience | 27.33 Mn | 20.23 Mn | 12.24 Mn | -33.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.24% |
| Dec 31, 2025 | -26.74% |
| Sep 30, 2025 | 18.65% |
| Jun 30, 2025 | 154.58% |
| Mar 31, 2025 | 51.88% |
| Dec 31, 2024 | 145.21% |
| Sep 30, 2024 | -8.46% |
| Jun 30, 2024 | -45.83% |
| Mar 31, 2024 | 10.60% |
| Dec 31, 2023 | 20.00% |
| Sep 30, 2023 | 39.77% |
| Jun 30, 2023 | 14.39% |
| Mar 31, 2023 | -14.22% |
| Dec 31, 2022 | 6.46% |
| Sep 30, 2022 | -40.99% |
| Jun 30, 2022 | -31.79% |
| Mar 31, 2022 | -44.03% |
| Dec 31, 2021 | -64.40% |
| Sep 30, 2021 | 22.79% |
| Jun 30, 2021 | -15.59% |